These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and neurobiological aspects of narcolepsy. Nishino S Sleep Med; 2007 Jun; 8(4):373-99. PubMed ID: 17470414 [TBL] [Abstract][Full Text] [Related]
3. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Nishino S; Kanbayashi T Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155 [TBL] [Abstract][Full Text] [Related]
4. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Lin L; Faraco J; Li R; Kadotani H; Rogers W; Lin X; Qiu X; de Jong PJ; Nishino S; Mignot E Cell; 1999 Aug; 98(3):365-76. PubMed ID: 10458611 [TBL] [Abstract][Full Text] [Related]
5. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. Gerashchenko D; Kohls MD; Greco M; Waleh NS; Salin-Pascual R; Kilduff TS; Lappi DA; Shiromani PJ J Neurosci; 2001 Sep; 21(18):7273-83. PubMed ID: 11549737 [TBL] [Abstract][Full Text] [Related]
6. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Tanaka S; Honda Y; Inoue Y; Honda M Sleep; 2006 May; 29(5):633-8. PubMed ID: 16774153 [TBL] [Abstract][Full Text] [Related]
7. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989 [TBL] [Abstract][Full Text] [Related]
8. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957 [TBL] [Abstract][Full Text] [Related]
9. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284 [TBL] [Abstract][Full Text] [Related]
10. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Hungs M; Fan J; Lin L; Lin X; Maki RA; Mignot E Genome Res; 2001 Apr; 11(4):531-9. PubMed ID: 11282968 [TBL] [Abstract][Full Text] [Related]
11. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400 [TBL] [Abstract][Full Text] [Related]
12. Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602. Black JL; Krahn LE; Pankratz VS; Silber M Sleep; 2002 Nov; 25(7):719-23. PubMed ID: 12405606 [TBL] [Abstract][Full Text] [Related]
13. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy. Williams RH; Tsunematsu T; Thomas AM; Bogyo K; Yamanaka A; Kilduff TS J Neurosci; 2019 Nov; 39(47):9435-9452. PubMed ID: 31628177 [TBL] [Abstract][Full Text] [Related]
14. The hypocretin/orexin system in health and disease. Nishino S Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797 [TBL] [Abstract][Full Text] [Related]
15. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings. Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990 [TBL] [Abstract][Full Text] [Related]
16. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy. Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605 [TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia]. Martínez-Rodríguez JE; Iranzo A; Casamitjana R; Graus F; Santamaria J Med Clin (Barc); 2007 Mar; 128(10):361-4. PubMed ID: 17386240 [TBL] [Abstract][Full Text] [Related]
18. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. De la Herrán-Arita AK; Kornum BR; Mahlios J; Jiang W; Lin L; Hou T; Macaubas C; Einen M; Plazzi G; Crowe C; Newell EW; Davis MM; Mellins ED; Mignot E Sci Transl Med; 2013 Dec; 5(216):216ra176. PubMed ID: 24353159 [TBL] [Abstract][Full Text] [Related]
19. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354 [TBL] [Abstract][Full Text] [Related]